BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1792467)

  • 1. Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates.
    Farrington CP
    Stat Med; 1991 Nov; 10(11):1733-44. PubMed ID: 1792467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.
    Miller C; Farrington CP; Harbert K
    Int J Epidemiol; 1992 Oct; 21(5):998-1006. PubMed ID: 1468866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia.
    Khetsuriani N; Sanadze K; Abuladze M; Tatishvili N
    Clin Microbiol Infect; 2020 Jun; 26(6):737-742. PubMed ID: 31707133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
    Takasu T; Mgone JM; Mgone CS; Miki K; Komase K; Namae H; Saito Y; Kokubun Y; Nishimura T; Kawanishi R; Mizutani T; Markus TJ; Kono J; Asuo PG; Alpers MP
    Epidemiol Infect; 2003 Oct; 131(2):887-98. PubMed ID: 14596530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
    Hirayasu K; Oshiro S; Nakada Y
    No To Hattatsu; 2010 Nov; 42(6):427-31. PubMed ID: 21077352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles.
    Lam T; Ranjan R; Newark K; Surana S; Bhangu N; Lazenbury A; Childs AM; Abbey I; Gibbon F; Thomas G; Singh J; Prabhakar P; Kaminska M; Lascelles K; Hacohen Y; Brown K; Lim M
    Eur J Paediatr Neurol; 2021 Sep; 34():43-49. PubMed ID: 34388650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978-2002).
    Bojinova VS; Dimova PS; Belopitova LD; Mihailov AS; Gatcheva NL; Mihneva ZG; Hristova MT
    Eur J Paediatr Neurol; 2004; 8(2):89-94. PubMed ID: 15253056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.
    Papetti L; Amodeo ME; Sabatini L; Baggieri M; Capuano A; Graziola F; Marchi A; Bucci P; D'Ugo E; Kojouri M; Gioacchini S; Marras CE; Nucci CG; Ursitti F; Sforza G; Ferilli MAN; Monte G; Moavero R; Vigevano F; Valeriani M; Magurano F
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiological features of subacute sclerosing panencephalitis.
    Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
    Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.